The company develops value-added products in two commercial segments, as transfection reagents for biomedical R&D enterprise and as nucleic acid delivery agents for preclinical and clinical applications. We design and develop unique materials for effective delivery of nucleic acids to meet the emerging needs in biomedical enterprise. We are dedicated to understanding the performance of our products in the hands of our customers to reveal the scientific basis of their actions. We work closely with our customers, fellow researchers and scientists to realize shared scientific and technical aspirations. We empower our product users to go further, to see beyond and overcome impediments that has not been possible before.